| Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting B Julg, L Dee, J Ananworanich, DH Barouch, K Bar, M Caskey, DJ Colby, ... The lancet HIV 6 (4), e259-e268, 2019 | 184 | 2019 |
| How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs? J Ananworanich, K Dubé, N Chomont Current Opinion in HIV and AIDS 10 (1), 18-28, 2015 | 150 | 2015 |
| Stigma and Ebola survivorship in Liberia: results from a longitudinal cohort study L Overholt, DA Wohl, WA Fischer, D Westreich, S Tozay, E Reeves, ... PloS one 13 (11), e0206595, 2018 | 83 | 2018 |
| Ebola virus ribonucleic acid detection in semen more than two years after resolution of acute Ebola virus infection WA Fischer, J Brown, DA Wohl, AJ Loftis, S Tozay, E Reeves, K Pewu, ... Open forum infectious diseases 4 (3), ofx155, 2017 | 74 | 2017 |
| Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US K Dubé, D Evans, L Sylla, J Taylor, BJ Weiner, A Skinner, H Thirumurthy, ... Journal of Virus Eradication 3 (1), 40-71, 2017 | 74 | 2017 |
| “We need to deploy them very thoughtfully and carefully”: Perceptions of analytical treatment interruptions in HIV cure research in the United States—A qualitative inquiry K Dubé, D Evans, L Dee, L Sylla, J Taylor, A Skinner, BJ Weiner, ... AIDS Research and Human Retroviruses 34 (1), 67-79, 2018 | 71 | 2018 |
| Towards multidisciplinary HIV-cure research: integrating social science with biomedical research CI Grossman, AL Ross, JD Auerbach, J Ananworanich, K Dubé, ... Trends in microbiology 24 (1), 5-11, 2016 | 71 | 2016 |
| 'Well, it's the risk of the unknown… right?': a qualitative study of perceived risks and benefits of HIV cure research in the United States K Dubé, J Taylor, L Sylla, D Evans, L Dee, A Burton, L Willenberg, ... PloS one 12 (1), e0170112, 2017 | 65 | 2017 |
| Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations SA Garner, S Rennie, J Ananworanich, K Dube, DM Margolis, ... Journal of Virus Eradication 3 (2), 82-84, 2017 | 62 | 2017 |
| Framing expectations in early HIV cure research K Dubé, GE Henderson, DM Margolis Trends in microbiology 22 (10), 547-549, 2014 | 61 | 2014 |
| Multi-stakeholder consensus on a target product profile for an HIV cure SR Lewin, T Attoye, C Bansbach, B Doehle, K Dubé, M Dybul, ... The Lancet HIV 8 (1), e42-e50, 2021 | 53 | 2021 |
| The LAIs are coming! Implementation science considerations for long-acting injectable antiretroviral therapy in the United States: a scoping review JT Kanazawa, P Saberi, JA Sauceda, K Dubé AIDS research and human retroviruses 37 (2), 75-88, 2021 | 49 | 2021 |
| A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption MJ Peluso, L Dee, D Campbell, J Taylor, R Hoh, RL Rutishauser, ... Journal of virus eradication 6 (1), 34-37, 2020 | 47 | 2020 |
| If we build it, will they come? Perceptions of HIV cure-related research by people living with HIV in four US cities: a qualitative focus group study L Sylla, D Evans, J Taylor, A Gilbertson, D Palm, JD Auerbach, K Dubé AIDS research and human retroviruses 34 (1), 56-66, 2018 | 47 | 2018 |
| Considerations for increasing racial, ethnic, gender, and sexual diversity in HIV cure-related research with analytical treatment interruptions: a qualitative inquiry K Dubé, J Kanazawa, C Campbell, CA Boone, AC Maragh-Bass, ... AIDS research and human retroviruses 38 (1), 50-63, 2022 | 45 | 2022 |
| Perceptions of equipoise, risk–benefit ratios, and “otherwise healthy volunteers” in the context of early-phase HIV cure research in the United States: a qualitative inquiry K Dubé, L Dee, D Evans, L Sylla, J Taylor, B Brown, V Miller, A Corneli, ... Journal of Empirical Research on Human Research Ethics 13 (1), 3-17, 2018 | 45 | 2018 |
| What lessons it might teach us? Community engagement in HIV research MY Karris, K Dube, AA Moore Current Opinion in HIV and AIDS 15 (2), 142-149, 2020 | 43 | 2020 |
| Applying the behavioural and social sciences research (BSSR) functional framework to HIV cure research K Dubé, JD Auerbach, MJ Stirratt, P Gaist African Journal of Reproduction and Gynaecological Endoscopy 22 (10), 2019 | 40 | 2019 |
| Research on HIV cure: mapping the ethics landscape K Dubé, L Sylla, L Dee, J Taylor, D Evans, CD Bruton, A Gilberston, ... PLoS medicine 14 (12), e1002470, 2017 | 37 | 2017 |
| Putting participants at the centre of HIV cure research K Dubé, L Barr, D Palm, B Brown, J Taylor The Lancet HIV 6 (3), e147-e149, 2019 | 36 | 2019 |
Bryan J WeinerUniversity of WashingtonVerified email at uw.edu